de Boer, Rudolf A.

Universal risk factors for multifactorial diseases: LifeLines: a three-generation population-based study

Stolk, R. P., Rosmalen, J. G. M., Postma, D. S., de Boer, R. A., Navis, G., Slaets, J. P. J., Ormel, J., & Wolffenbuttel, B. H. R. (2008) · European Journal of Epidemiology

Genetic Associations and EpidemiologyHealth, Environment, Cognitive Aging

Cited by 391

Heart failure with preserved ejection fraction: from mechanisms to therapies

Lam, C. S. P., Voors, A. A., de Boer, R. A., Solomon, S. D., & van Veldhuisen, D. J. (2018) · European Heart Journal

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 355

Vitamin D supplementation and testosterone concentrations in male human subjects

Heijboer, A. C., Oosterwerff, M., Schroten, N. F., Eekhoff, E. M. W., Chel, V. G. M., de Boer, R. A., Blankenstein, M. A., & Lips, P. (2015) · Clinical Endocrinology

Vitamin D Research StudiesHormonal and reproductive studies

Cited by 63

Risk Factors for Immune Checkpoint Inhibitor–Mediated Cardiovascular Toxicities

Yousif, L. I., Screever, E. M., Versluis, D., Aboumsallem, J. P., Nierkens, S., Manintveld, O. C., de Boer, R. A., & Meijers, W. C. (2023) · Current Oncology Reports

Cancer Immunotherapy and BiomarkersChemotherapy-induced cardiotoxicity and mitigation

Cited by 51

Galectin-3 increase in endurance athletes

Hättasch, R., Spethmann, S., de Boer, R. A., Ruifrok, W. P., Schattke, S., Wagner, M., Schroeckh, S., Durmus, T., Schimke, I., Sanad, W., et al. (2014) · European Journal of Preventive Cardiology

Cardiovascular Effects of ExerciseCardiac Fibrosis and Remodeling

Cited by 46